ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019

Go back to ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019

ResMed (RMD) Tops Q3 EPS by 4c, Revenues Beat

May 2, 2019 4:24 PM EDT

ResMed (NYSE: RMD) reported Q3 EPS of $0.89, $0.04 better than the analyst estimate of $0.85. Revenue for the quarter came in at $662.2 million versus the consensus estimate of $657.77 million.

Revenue increased 12% to $662.2 million; up 15% on a constant currency basisGross margin expanded 100bps to... More